Melanoma brain metastases: review of histopathological features and immune-molecular aspects

Patients with melanoma brain metastases (MBM) have a dismal prognosis, but the unprecedented advances in systemic therapy alone or in combination with local therapy have now extended the 1-year overall survival rate from 20–25% to nearing 80–85%, mainly in asymptomatic patients. The histopathologica...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvati, Lorenzo, Mandalà, Mario, Massi, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426753/
https://www.ncbi.nlm.nih.gov/pubmed/32821376
http://dx.doi.org/10.2217/mmt-2019-0021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426753/
https://www.ncbi.nlm.nih.gov/pubmed/32821376
http://dx.doi.org/10.2217/mmt-2019-0021

Ejemplares similares